Online Database of Chemicals from Around the World

6,7,8,9-Tetrahydro-3-[2-[4-(6-hydroxy-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
[CAS# 106266-11-9]

List of Suppliers
CAS: 106266-11-9
Product: 6,7,8,9-Tetrahydro-3-[2-[4-(6-hydroxy-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
No suppilers available.
Identification
Name 6,7,8,9-Tetrahydro-3-[2-[4-(6-hydroxy-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
Molecular Structure CAS # 106266-11-9, 6,7,8,9-Tetrahydro-3-[2-[4-(6-hydroxy-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
Molecular Formula C23H28N4O3
Molecular Weight 408.49
CAS Registry Number 106266-11-9
Properties
Solubility Practically insoluble (0.049 g/L) (25 ºC), Calc.*
Density 1.40±0.1 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2015 ACD/Labs)
Market Analysis Reports
List of Reports Available for 6,7,8,9-Tetrahydro-3-[2-[4-(6-hydroxy-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
Related Products
1-(Tetrahydro-2-furoyl)piperazine  9-(Tetrahydro-2-furyl)adenine  (R)-(+)-Tetrahydro-3-furylamine p-toluenesulfonate salt  1-(Tetrahydro-2-furylmethyl)piperazine  1-(Tetrahydro-2-furyl)-3-(1-naphthyl)propane-2,2-dicarboxylic acid  1-(3-Tetrahydrofuryl)-1H-pyrazole-4-boronic acid pinacol ester  Tetrahydrogen [C-[[(3-amino-4-sulfophenyl)amino]sulfonyl]-29H,31H-phthalocyanine-C,C,C-trisulfonato-N29,N30,N31,N32]nickelate  tetrahydrogen [2-[[4-chloro-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-5-hydroxy-6-[(2-hydroxy-5-sulfophenyl)azo]-1,7-naphthalenedisulfonato(6-)]-Cuprate(4-)  Tetrahydrogenoxo[29H,31H-phthalocyaninetetracarboxylato]vanadate  2,3,4,5-Tetrahydro-4-hydroxy-1H-2-benzazepin-1-one  2,3,4,5-Tetrahydro-7-hydroxy-1H-benzofuro[2,3-c]azepin-1-one  1,2,3,4-Tetrahydro-9-hydroxy-5H-[1]benzopyrano[3,4-b]pyridin-5-one  2,3,6,7-Tetrahydro-8-hydroxy-1H,5H-benzo[ij]quinolizine-9-carboxaldehyde  (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis([1,1'-biphenyl]-4-yl)-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide  (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis([1,1'-biphenyl]-4-yl)-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide  (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis(4-chlorophenyl)-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide  (2R,3R,3aS,9aR)-2,3,3a,9a-Tetrahydro-3-hydroxy-2,9a-bis(hydroxymethyl)-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one  (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis(4-nitrophenyl)-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide  (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis(4-nitrophenyl)-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide  (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-tris(1-methylethyl)phenyl]-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide